Detalhe da pesquisa
1.
Neurodevelopmental and other phenotypes recurrently associated with heterozygous BAZ2B loss-of-function variants.
Am J Med Genet A
; 194(3): e63445, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872713
2.
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial.
Ann Rheum Dis
; 78(1): 51-59, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30309970
3.
Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Ann Rheum Dis
; 74(7): 1379-86, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641940
4.
Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.
Rheumatology (Oxford)
; 54(11): 1964-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26078219
5.
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial.
Pediatr Rheumatol Online J
; 22(1): 53, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38730442
6.
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.
Ann Rheum Dis
; 72(5): 721-7, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22730374
7.
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
Rheumatology (Oxford)
; 52(4): 712-7, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23267169
8.
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
Rheumatology (Oxford)
; 52(9): 1674-9, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740187
9.
Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow up.
Pediatr Rheumatol Online J
; 21(1): 90, 2023 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633893
10.
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
Ann Rheum Dis
; 70(2): 337-40, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21068101
11.
An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register.
Rheumatology (Oxford)
; 50(6): 1131-6, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21278067
12.
Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
JAMA
; 306(21): 2340-7, 2011 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22056397
13.
Loss of ADAM17 is associated with severe multiorgan dysfunction.
Hum Pathol
; 46(6): 923-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25804906
14.
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.
J Rheumatol
; 38(10): 2258-63, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21844151
15.
[Serious gastrointestinal complications due to accidental ingestion of magnetic toy parts]. / Ernstige gastro-intestinale complicaties door inslikken van magnetisch speelgoed.
Ned Tijdschr Geneeskd
; 154: A1917, 2010.
Artigo
em Holandês
| MEDLINE | ID: mdl-20699028
16.
Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept.
J Rheumatol
; 37(3): 665-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20080910